BETA AMYLOID POLYCLONAL ANTIBODY IMMUNOGENICITY AS EARLY DEVELOPMENT STUDY OF EARLY DIAGNOSIS FOR ALZHEIMER’S DISEASE

Muhamad Rasjad Indra, Eko Arisetijono Marhaendraputro, Rudi Rakhmad Hidayat
  MNJ, pp. 1-4  

Abstract


Background. Alzheimer's disease is a progressive neurologic disease of the brain that triggers irreversible neuronal cell loss, which can interfere with social and occupational functioning. The theory of ACH (Amyloid Cascade Hypothesis) states there are deposits and misfolding of beta amyloid protein thus lead to the formation of plaques and tangles in neurons cells.
Objective. To identify the immunogenicity of beta amyloid polyclonal antibodies that can be developed as a first step early diagnosis of Alzheimer's disease.
Methods. Rrandomized group post test only design conducted on rabbits. Blood samples were taken from rabbits that had been injected antigen once a week for 5 weeks. Variables were found in this study is the formation of beta amyloid polyclonal antibody with detection levels using dot blot and ELISA methods.
Results. It has been reproduced specific polyclonal antibody beta amyloid which has been evidenced by the bond between the antigen with the antibody in a dot blot.
Conclusion. The beta amyloid antibodies can be produced through production techniques with a polyclonal antibody against beta amyloid antigen induced rabbit.

Keywords


Alzheimer's disease; antibodies; beta amyloid

Full Text:

Untitled PDF

References


Berchtold NC, Cotman CW. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol. Aging. 2008;19(3):173–89.

Lahiri DK, Maloney B. "Beyond the signaling effect role of amyloid–β42 on the processing of AβPP, and its clinical implications". Exp. Neurol. 2010;225 (1): 51–4.

Brookmeyer R, Johnson E, Ziegler-Graham K, MH Arrighi. Forecasting the global burden of Alzheimer's disease. Alzheimer's and Dementia. 2007 [cited 2008-06-18];3(3):186–91.

G. Glenner and C. W. Wong, “Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein,” Biochemical and Biophysical Research Communications, 2004, vol. 122, no. 3, pp.1131–1135.

Abbas AK, Licthman AH. Basic Immunology edisi 3. Saunders. 2010.

Anoop, A., Pradeep K. Singh., Reeba S. Jacob., and Samir K. Maji. CSF Biomarkers for Alzheimer's Disease Diagnosis. Int J Alzheimer Dis. 2010; 2010: 606802. Published online Jun 23, 2010. doi: 10.4061/2010/606802. PMCID:PMC291579.


Refbacks

  • There are currently no refbacks.